Latest News

InMode Ltd. recently issued updated earnings guidance, projecting fourth-quarter 2025 revenue of about US$103.6 million to US$103.8 million, full-year 2025 revenue of roughly US$370.2 million to US$370.4 million, and full-year 2026 revenue of US$365 million to US$375 million. This guidance gives investors a clearer view of InMode’s expected revenue trajectory over the next two years, which can be weighed against prior expectations for moderating earnings and margin compression in its...

In early January 2026, Technip Energies reported winning two large contracts from Bharat Petroleum Corporation Limited to deliver EPCC services for new polypropylene and Butene-1 units at BPCL’s Bina refinery and EPCm services for India’s first 3 MMTPA Petro Resid Fluidized Catalytic Cracker unit at the Mumbai refinery. These awards, together valued between €250 million and €500 million, deepen a decades-long relationship with BPCL and underline Technip Energies’ role in building India’s...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...

dentalcorp Holdings (TSX:DNTL) has attracted fresh attention after its recent share performance, with investors weighing its current CA$10.97 price against fundamentals such as revenue, earnings trend, and longer term total returns. See our latest analysis for dentalcorp Holdings. While the recent share price return figures for dentalcorp are fairly modest over shorter periods, the 1 year total shareholder return of 36.1% and 3 year total shareholder return of 21.4% suggest momentum has been...

With its stock down 8.7% over the past three months, it is easy to disregard RITES (NSE:RITES). It seems that the...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

With a price-to-earnings (or "P/E") ratio of 10.7x Aries Agro Limited ( NSE:ARIES ) may be sending very bullish signals...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights Significant insider control over Page Industries implies vested interests in company growth The top 6...

Key Insights K.P.R. Mill's significant insider ownership suggests inherent interests in company's expansion A total of...

With a price-to-earnings (or "P/E") ratio of 16.9x Uniparts India Limited ( NSE:UNIPARTS ) may be sending bullish...

It is hard to get excited after looking at Voltamp Transformers' (NSE:VOLTAMP) recent performance, when its stock has...

DLF (NSE:DLF) has had a rough three months with its share price down 9.4%. But if you pay close attention, you might...

With a price-to-earnings (or "P/E") ratio of 42x Patanjali Foods Limited ( NSE:PATANJALI ) may be sending very bearish...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Key Insights Insiders appear to have a vested interest in Kitex Garments' growth, as seen by their sizeable ownership...

Buying shares in the best businesses can build meaningful wealth for you and your family. While not every stock...

Key Insights GMR Airports' estimated fair value is ₹198 based on 2 Stage Free Cash Flow to Equity GMR Airports is...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

If you are wondering whether J&J Snack Foods shares offer good value right now, the first step is understanding how the current price lines up with what the business might be worth. The stock last closed at US$94.85, with a 7 day return of 4.8%, a 30 day return of 0.9%, a year to date return of 4.8%, and a 1 year return of a 31.1% decline, which can change how investors think about both risk and potential opportunity. Recent coverage of J&J Snack Foods has focused on its position in the...

In recent commentary, SIGA Technologies has been highlighted as a niche biodefense pharmaceutical company with a highly profitable TPOXX antiviral franchise, a strong balance sheet, and contracts primarily with government agencies for smallpox treatment. An interesting angle is how SIGA’s combination of substantial free cash flow, minimal debt, and focus on a single government-backed product is shaping its appeal as a perceived deep-value biodefense play. Next, we’ll examine how SIGA’s...

With a price-to-earnings (or "P/E") ratio of 47x Polycab India Limited ( NSE:POLYCAB ) may be sending very bearish...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...